HK BiocodeHK Biocode

Why early detection matters

The earlier a change is noticed, the more can be done about it.

Early breast-health awareness is one of the most powerful levers we have. It raises survival rates, reduces the burden of treatment, and gives women agency over their health in the long months between scheduled screenings.

Earlier intervention saves lives

Breast cancer found early is more treatable. A signal that prompts timely imaging gives clinicians the chance to act before a cancer advances.

Interval cancers are real

Cancers can develop or progress in the 6–24 month gap between scheduled scans. Staying watchful through that window is precisely the point.

Lower treatment burden

Earlier-stage disease often means less aggressive treatment, lower cost, and a gentler path for the patient and her family.

Screening avoidance is common

Access, time, fear, discomfort, or a low sense of personal risk lead many women to delay. A calm home routine lowers the barrier to staying engaged.

Self-awareness

Look. Feel. Compare.

The earlier a change is noticed, the sooner it can be checked.

Regular breast self-awareness helps women understand what is normal for their own body. Many Hong Kong and Asian breast health organisations encourage women to check their breasts once a month using a simple routine: look, feel, and compare.

A self-check does not replace medical screening, but it can help women notice unusual changes earlier and seek professional advice sooner.

Where it fits

An adjunctive layer between points of care

Home monitoring does not stand alone. It sits inside the standard pathway — a risk signal that a nurse or physician reviews, leading to imaging referral only when indicated.

  1. 1At-home monthly monitoring
  2. 2Risk signal / report
  3. 3Nurse or physician review
  4. 4Imaging referral if indicated
  5. 5Standard diagnostic pathway
Illustration of breast anatomy highlighting early changes

Who it can help

Built around real lives

Breast Guardian is designed for asymptomatic, screening-age women who want to stay engaged with their breast health — and for the clinicians who guide them.

  • Women between scheduled breast-imaging appointments
  • Women below routine-screening age but with elevated concern or risk factors
  • Women with dense breasts, where reassurance between imaging can help
  • Women with low screening adherence who may accept home monitoring
  • Survivorship and post-treatment follow-up — subject to clinical oversight

A responsible-use note

Breast Guardian does not diagnose cancer, and it is never a verdict of “cancer” or “no cancer.” A normal result must not be used to defer recommended screening, and an elevated result should trigger appropriate clinical follow-up — interpreted within a broader clinical context. It complements mammography, ultrasound, and MRI; it does not replace them.

Take the next step

Want to bring earlier awareness to the women you care for?

We work with clinics, insurers, and health organisations to introduce responsible at-home monitoring. We would love to hear from you.